196 related articles for article (PubMed ID: 29126904)
1. Enhancement of tioconazole ungual delivery: Combining nanocapsule formulation and nail poration approaches.
Flores FC; Chiu WS; Beck RCR; da Silva CB; Delgado-Charro MB
Int J Pharm; 2018 Jan; 535(1-2):237-244. PubMed ID: 29126904
[TBL] [Abstract][Full Text] [Related]
2. An innovative polysaccharide nanobased nail formulation for improvement of onychomycosis treatment.
Flores FC; Rosso RS; Cruz L; Beck RC; Silva CB
Eur J Pharm Sci; 2017 Mar; 100():56-63. PubMed ID: 28063967
[TBL] [Abstract][Full Text] [Related]
3. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
Khattab A; Shalaby S
AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
[TBL] [Abstract][Full Text] [Related]
4. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
[TBL] [Abstract][Full Text] [Related]
5. Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis.
Tanrıverdi ST; Özer Ö
Eur J Pharm Sci; 2013 Mar; 48(4-5):628-36. PubMed ID: 23295582
[TBL] [Abstract][Full Text] [Related]
6. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation.
Tanrıverdi ST; Hilmioğlu Polat S; Yeşim Metin D; Kandiloğlu G; Özer Ö
J Liposome Res; 2016; 26(2):163-73. PubMed ID: 26226352
[TBL] [Abstract][Full Text] [Related]
7. Precise laser poration to control drug delivery into and through human nail.
Vanstone S; Cordery SF; Stone JM; Gordeev SN; Guy RH
J Control Release; 2017 Dec; 268():72-77. PubMed ID: 29051061
[TBL] [Abstract][Full Text] [Related]
8. Ciclopirox vs amorolfine: in vitro penetration into and permeation through human healthy nails of commercial nail lacquers.
Monti D; Tampucci S; Chetoni P; Burgalassi S; Mailland F
J Drugs Dermatol; 2014 Feb; 13(2):143-7. PubMed ID: 24509963
[TBL] [Abstract][Full Text] [Related]
9. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
Pal P; Thakur RS; Ray S; Mazumder B
Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
[TBL] [Abstract][Full Text] [Related]
10. Development of ciclopirox nail lacquer with enhanced permeation and retention.
Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
[TBL] [Abstract][Full Text] [Related]
11. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.
Nair AB; Kim HD; Chakraborty B; Singh J; Zaman M; Gupta A; Friden PM; Murthy SN
J Pharm Sci; 2009 Nov; 98(11):4130-40. PubMed ID: 19340887
[TBL] [Abstract][Full Text] [Related]
12. New Formulation-Microporation Combination Approaches to Delivering Ciclopirox across Human Nails.
Kishishita J; de Almeida Perez Pimenta C; Cerqueira Macedo DP; Delgado-Charro MB; Bastos Leal L
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258083
[TBL] [Abstract][Full Text] [Related]
13. Transungual permeation: current insights.
Bhuptani RS; Deshpande KM; Patravale VB
Drug Deliv Transl Res; 2016 Aug; 6(4):426-39. PubMed ID: 26419676
[TBL] [Abstract][Full Text] [Related]
14. Trans-ungual iontophoretic delivery of terbinafine.
Nair AB; Vaka SR; Sammeta SM; Kim HD; Friden PM; Chakraborty B; Murthy SN
J Pharm Sci; 2009 May; 98(5):1788-96. PubMed ID: 18781625
[TBL] [Abstract][Full Text] [Related]
15. Assessment of iontophoretic and passive ungual penetration by laser scanning confocal microscopy.
Dutet J; Delgado-Charro MB
Pharm Res; 2012 Dec; 29(12):3464-74. PubMed ID: 22869107
[TBL] [Abstract][Full Text] [Related]
16. Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers.
Khengar RH; Jones SA; Turner RB; Forbes B; Brown MB
Pharm Res; 2007 Dec; 24(12):2207-12. PubMed ID: 17665289
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the nail permeability of topically applied drugs.
Murdan S
Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
[TBL] [Abstract][Full Text] [Related]
18. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
19. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
Elsherif NI; Shamma RN; Abdelbary G
AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
[TBL] [Abstract][Full Text] [Related]
20. Controlled nail delivery of a novel lipophilic antifungal agent using various modern drug carrier systems as well as in vitro and ex vivo model systems.
Naumann S; Meyer JP; Kiesow A; Mrestani Y; Wohlrab J; Neubert RH
J Control Release; 2014 Apr; 180():60-70. PubMed ID: 24560884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
